Wound Healing
Wound healing is a complex, tightly regulated sequence of biological events that restores the structure and function of the skin after injury. It runs continuously through four overlapping phases: hemostasis, inflammation, proliferation and remodeling. Each phase depends on coordinated work by several cell types (platelets, neutrophils, macrophages, fibroblasts, endothelial cells and keratinocytes), by growth factors (PDGF, TGF-beta, VEGF, EGF) and by matrix-degrading enzymes (MMPs). A disruption at any stage – from infection, poor blood supply, mechanical tension or immune dysfunction – pushes healing toward one of two extremes: a chronic wound that will not close (such as a venous or diabetic ulcer), or uncontrolled fibrous overgrowth that produces hypertrophic or keloid scars. At Haute-Derma, we manage wounds according to the TIME framework and combine it with photobiomodulation, growth factors and regenerative techniques to help wounds heal faster and minimize the risk of poor scarring.
The cellular and immunologic biology of healing:
- Phase 1: Hemostasis and the Early Fibrin Scaffold
- As soon as a blood vessel is injured, it reflexively constricts and the collagen beneath the endothelium is exposed.
- Platelets clump together and trigger the clotting cascade, which lays down a fibrin–fibronectin mesh that serves as a temporary scaffold. Platelets also release alpha granules containing PDGF, TGF-beta and EGF, which recruit immune cells.
- Phase 2: Inflammation and the M1-to-M2 Macrophage Switch
- Over the first 24–48 hours, neutrophils clear bacteria and cell debris by releasing reactive oxygen species (ROS) and protease enzymes.
- Macrophages arrive next. Early on, pro-inflammatory M1 macrophages secrete TNF-alpha and IL-1beta to kill pathogens. They then shift to an anti-inflammatory, reparative M2 state and secrete TGF-beta and VEGF, which launch the proliferative phase.
- Phase 3: Proliferation – Granulation Tissue, New Vessels and Re-epithelialization
- Fibroblasts migrate into the fibrin scaffold and produce type III collagen and proteoglycans, building granulation tissue.
- VEGF drives endothelial cells to form new capillaries (angiogenesis). At the same time, keratinocytes at the wound edge migrate across the granulation tissue to close the surface (re-epithelialization).
- Phase 4: Remodeling – Collagen Turnover and Scar Formation
- Under the influence of TGF-beta1, fibroblasts turn into myofibroblasts, which express alpha-SMA and pull the wound edges together.
- Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) break down the delicate type III collagen and replace it with sturdier type I collagen. Contraction and realignment of collagen fibers continue from about month 3 for up to a year or more, giving the scar its tensile strength – which peaks at around 80% of the original skin.
Clinical Signs and Cellular Activity in Each Healing Phase
| Healing Phase | Time Frame | What You See on the Skin |
|---|---|---|
| 1. Hemostasis | Immediately to a few minutes | A clot forms, plasma seeps into the surrounding tissue, mild swelling. |
| 2. Inflammation | Day 1 to day 4 | Wound edges are swollen, red, warm and tender; clear or slightly cloudy discharge. |
| 3. Proliferation | Day 4 to day 21 | Moist, beefy red, soft granulation tissue that bleeds easily on touch; new skin creeps in from the edges. |
| 4. Remodeling | Week 3 to 1–2 years | The scar fades from pink-red to paler, gradually flattens and gains tensile strength. |
Normal Healing vs. Chronic Wounds vs. Pathologic Scarring
| Normal Physiologic Healing | Chronic (Non-Healing) Wound | Excessive Healing (Keloid / Hypertrophic Scar) |
|---|---|---|
| Short inflammation with a smooth M1-to-M2 transition | Stuck in the M1 state with intense chronic inflammation | Prolonged low- to moderate-grade inflammation |
| MMPs and TIMPs balanced, released in the right amounts | Excess MMPs that degrade growth factors | Low MMPs or excess TIMPs, so less collagen is broken down |
| Adequate new vessels, bright pink-red granulation tissue | Poor vessel growth, pale gray or necrotic granulation tissue | Prolonged vessel growth and excessive collagen production |
| Type I collagen laid down in parallel bundles | Disordered synthesis and a broken-down extracellular matrix | Haphazard buildup of type I/III collagen in tangled whorls |
| Flat, fine scar with good recovery of tensile strength | Loss of skin surface; a deep ulcer that persists and will not close | Raised, red, itchy scar that spreads beyond the original injury |
Our Approach
At Haute-Derma, we assess every wound in a standardized way using the TIME framework:
- T – Tissue: Using magnification and dermoscopy, we estimate the proportion of red granulation tissue, yellow slough and black necrotic tissue to decide on the right kind of cleansing and debridement.
- I – Infection / Inflammation: We separate normal inflammation from true wound infection (cloudy pus, foul odor, spreading redness, worsening pain). If infection is suspected, a swab is sent for culture and antibiotic sensitivity testing.
- M – Moisture balance: We gauge the amount of exudate: too little (a dry wound slows keratinocyte migration) or too much (heavy exudate softens and breaks down the wound edges, known as maceration).
- E – Edge / epithelial advancement: We check whether the wound edges are rolled under (epibole) or fibrotic, or whether keratinocytes are advancing well across the surface.
Treatments at Haute-Derma
Our wound-care protocols target each biological phase precisely to make recovery as efficient as possible:
- Managing the Wound Bed and Environment (TIME Framework):
- Cleansing and conservative debridement: Necrotic tissue and biofilm are removed using gentle antiseptic solutions containing hypochlorous acid (HOCl) or polyhexanide (PHMB).
- Advanced dressings: Hydrogel dressings add moisture to dry wounds, while silver-containing alginate or Hydrofiber dressings absorb exudate and control bacteria in heavily draining wounds.
- Regenerative and Cell-Boosting Therapies at Haute-Derma:
- Platelet-rich plasma (PRP) / exosomes: Deliver high local concentrations of PDGF, TGF-beta and VEGF to stimulate new vessel growth and keratinocyte migration in slow-healing wounds.
- Red (630 nm) and near-infrared (830 nm) LED therapy: Boosts mitochondrial ATP production, shortens the inflammatory phase and encourages fibroblasts to lay down normal collagen.
- Early Prevention and Treatment of Abnormal Scars:
- Silicone gel sheeting is applied as soon as the surface has fully closed. It reduces transepidermal water loss (TEWL) and dampens TGF-beta1 signaling, helping to prevent keloid and hypertrophic scars.
